Generate Biomedicines, Inc.
- Ticker
- GENB
- CIK
- 2100782
- Industry
- Pharmaceutical Preparations
Financials 3
News 5
Ownership 35
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
Prospectus 6
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- 424B4 Prospectus filed pursuant to Rule 424(b)(4)
- S-1/A General form of registration statement for all companies including face-amount certificate companies
- S-1/A General form of registration statement for all companies including face-amount certificate companies
- S-1 General form of registration statement for all companies including face-amount certificate companies
- DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Other 9
- SCHEDULE 13G
- 144 Filing for proposed sale of securities under Rule 144
- 144 Filing for proposed sale of securities under Rule 144
- 144 Filing for proposed sale of securities under Rule 144
- SCHEDULE 13G
- SCHEDULE 13G
- EFFECT Notice of Effectiveness
- CERT Certification by an exchange approving securities for listing
- 8-A12B Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)